Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Mark Rasmussen, Daniel W. Bougie, PhD, Gregory H. Denomme, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 1078.

https://doi.org/10.1182/blood-2019-130966

Published: 2019

Journal Articles

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Matthew John Slaught, BS, Daniel W. Bougie, PhD, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 2350.

https://doi.org/10.1182/blood-2019-131375

Published: 2019

Journal Articles

Novel Combination Therapy Targeting rDNA Transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM

Kylee H Maclachlan, BSc, MBChB, FRACP, FRCPA, Andrew Cuddihy, PhD, Nadine Hein, PhD, Carleen Cullinane, PhD, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Ross Hannan, PhD, Gretchen Poortinga, PhD

Blood (2018) 132 (Supplement 1): 1945.

https://doi.org/10.1182/blood-2018-99-113765

Published: 2018

Journal Articles

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Michael Scordo, MD, Gunjan L. Shah, MD, Elaina V. Preston, PA-C, MPH, Natasia Rodriguez, BSN, RN, Andrew Lin, PharmD, BCOP, Molly Maloy, MS, Brooke Mastrogiacomo, BS, Dean Carlow, MD PhD, Ryan Schofield, MS, Andrea Knezevic, MS, Sean M Devlin, PhD, Heather J. Landau, MD, David J. Chung, MD PhD, Jonathan U. Peled, MD PhD, Marissa L. Buchan, MS, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2018-99-114715

Published: 2018

Journal Articles

RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study

Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Natalie Brajanovski, BSc, Donald P Cameron, BSc, Gretchen Poortinga, PhD, Elaine Sanij, PhD, John Lim, PharmD, John Soong, MD FCAP, Nadine Hein, PhD, Emma Link, DPhil, Richard B Pearson, PhD, Ross Hannan, Grant A. McArthur, MBBS, PhD BSc, FRACP, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD

Blood (2017) 130 (Supplement 1): 3835.

https://doi.org/10.1182/blood.V130.Suppl_1.3835.3835

Published: 2017

Journal Articles

Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma

Kylee H Maclachlan, FRACP,FRCPA, Andrew Cuddihy, PhD, Nadine Hein, PhD, Carleen Cullinane, PhD, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, Ross Hannan, PhD, Gretchen Poortinga, PhD

Blood (2017) 130 (Supplement 1): 1805.

https://doi.org/10.1182/blood.V130.Suppl_1.1805.1805

Published: 2017

Journal Articles

Quinine-Induced Thrombotic Microangiopathy (Q-TMA): Frequency, Presenting Features, Outcomes

Evaren E Page, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2016) 128 (22): 1381.

https://doi.org/10.1182/blood.V128.22.1381.1381

Published: 2016

Journal Articles

Binding of Quinine-Dependent Monoclonal Antibodies to Gpiib/Iiia Appears to Involve Drug-Induced Modulation of Antibody Affinity

Daniel W. Bougie, PhD, Julie A. Peterson, PhD, Mark Rasmussen, Richard H. Aster, MD

Blood (2015) 126 (23): 2246.

https://doi.org/10.1182/blood.V126.23.2246.2246

Published: 2015

Journal Articles

Structural Basis for Quinine-Dependent Antibody Binding to Platelet Integrin alphaIIbbeta3

Jianghai Zhu, PhD, Jieqing Zhu, PhD, Daniel W. Bougie, PhD, Richard H. Aster, MD, Timothy A. Springer, PhD

Blood (2015) 126 (23): 1063.

https://doi.org/10.1182/blood.V126.23.1063.1063

Published: 2015

Journal Articles

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Jordan M Morton, MD, Evaren E Page, MPH, Nathan W Liles, MD MPH, James N. George, MD

Blood (2015) 126 (23): 4651.

https://doi.org/10.1182/blood.V126.23.4651.4651

Published: 2015

Journal Articles

Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa

Daniel W. Bougie, Julie Peterson, Mark Rasmussen, Richard H. Aster

Blood (2015) 126 (18): 2146–2152.

https://doi.org/10.1182/blood-2015-04-643148

Published: 2015

Journal Articles

Structural basis for quinine-dependent antibody binding to platelet integrin α IIb β 3

Jianghai Zhu, Jieqing Zhu, Daniel W. Bougie, Richard H. Aster, Timothy A. Springer

Blood (2015) 126 (18): 2138–2145.

https://doi.org/10.1182/blood-2015-04-639351

Published: 2015

Journal Articles

Expanding the binding model of DITP

Renhao Li

Blood (2015) 126 (18): 2080–2081.

https://doi.org/10.1182/blood-2015-09-666586

Published: 2015

Journal Articles

Drug-induced thrombotic microangiopathy: a systematic review of published reports

Zayd L. Al-Nouri, Jessica A. Reese, Deirdra R. Terrell, Sara K. Vesely, James N. George

Blood (2015) 125 (4): 616–618.

https://doi.org/10.1182/blood-2014-11-611335

Published: 2015

Includes: Supplemental data

Journal Articles

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

Blood (2014) 124 (2): 167–175.

https://doi.org/10.1182/blood-2014-02-555953

Published: 2014

Includes: Supplemental data

Journal Articles

AML At First Relapse: A Real Life Picture

Eileen Mary Boyle, MD, Claude Preudhomme, MD, PhD, Olivier Nibourel, Catherine Roche-Lestienne, PhD, Gareth J Morgan, MD PhD, Brigitte Dupriez, MD, Isabelle Plantier, MD, Berengere Gruson, MD, Jean Pierre Marolleau, MD, PhD, Delphine Lebon, MD, Jose Fernandes, MD, Christophe Willekens, Bruno Quesnel, MD, PhD, Céline Berthon, MD, PhD

Blood (2013) 122 (21): 3895.

https://doi.org/10.1182/blood.V122.21.3895.3895

Published: 2013

Journal Articles

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Ervis Bezati, Xiao Xuan Wu, MD, Jacob H. Rand, MD

Blood (2012) 120 (21): 3423.

https://doi.org/10.1182/blood.V120.21.3423.3423

Published: 2012

Journal Articles

Genetic Heterogeneity of Alpha - and Beta - Globin Mutations in a German Multiethnic Population Group

Regine Grosse, MD, Florian Oyen, Belinda Weber, Reinhard Schneppenheim, MD, PhD

Blood (2012) 120 (21): 5185.

https://doi.org/10.1182/blood.V120.21.5185.5185

Published: 2012

Journal Articles

The Antimalarial Agent Artesunate Overcomes Bortezomib Resistance in Myeloma Cell Lines Through Non-Caspase Mediated Apoptosis

Xenofon Papanikolaou, MD, Ruslana Tytarenko, Tarun K. Garg, PhD, Sarah K. Johnson, PhD, Erming Tian, Senu Apewokin, MD, Bart Barlogie, MD, Joshua Epstein, DSc, Christoph Heuck, MD

Blood (2012) 120 (21): 4015.

https://doi.org/10.1182/blood.V120.21.4015.4015

Published: 2012

Journal Articles

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

Neil Shah, M.D., Karen Matevosyan, MD, James Burner, M.D., Ravindra Sarode, MD

Blood (2011) 118 (21): 2328.

https://doi.org/10.1182/blood.V118.21.2328.2328

Published: 2011

NARROW

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Cross-Reactivity of Drug-Dependent Antibodies in Patients with Immune Thrombocytopenia Induced By Beta-Lactam Antibiotics

Novel Combination Therapy Targeting rDNA Transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study

Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma

Quinine-Induced Thrombotic Microangiopathy (Q-TMA): Frequency, Presenting Features, Outcomes

Binding of Quinine-Dependent Monoclonal Antibodies to Gpiib/Iiia Appears to Involve Drug-Induced Modulation of Antibody Affinity

Structural Basis for Quinine-Dependent Antibody Binding to Platelet Integrin alphaIIbbeta3

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa

Structural basis for quinine-dependent antibody binding to platelet integrin α IIb β 3

Expanding the binding model of DITP

Drug-induced thrombotic microangiopathy: a systematic review of published reports

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

AML At First Relapse: A Real Life Picture

A Potential Antithrombotic Trick for an Old Drug: Quinine Inhibits the Binding of Antiphospholipid Antibody-β2-Glycoprotein I Immune Complexes to Phospholipid Bilayers in Vitro

Genetic Heterogeneity of Alpha - and Beta - Globin Mutations in a German Multiethnic Population Group

The Antimalarial Agent Artesunate Overcomes Bortezomib Resistance in Myeloma Cell Lines Through Non-Caspase Mediated Apoptosis

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only